Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Apollo Endosurgery Inc (APEN)

Apollo Endosurgery Inc (APEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,549
  • Shares Outstanding, K 20,944
  • Annual Sales, $ 60,850 K
  • Annual Income, $ -45,790 K
  • 60-Month Beta 0.80
  • Price/Sales 1.09
  • Price/Cash Flow N/A
  • Price/Book 5.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.34
  • Number of Estimates 1
  • High Estimate -0.34
  • Low Estimate -0.34
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +30.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.68 +0.75%
on 02/21/20
3.28 -17.68%
on 01/28/20
-0.29 (-9.70%)
since 01/21/20
3-Month
2.50 +8.00%
on 12/06/19
3.28 -17.68%
on 01/28/20
-0.20 (-6.90%)
since 11/21/19
52-Week
2.50 +8.00%
on 12/06/19
4.08 -33.82%
on 05/15/19
-0.81 (-23.08%)
since 02/21/19

Most Recent Stories

More News
5 ETFs & Stocks to Profit From One-Year High U.S. Inflation

The annual U.S. inflation for the month of November beat expectations and put these ETFs and stocks in focus.

KSU : 174.23 (-0.99%)
IYR : 100.21 (+0.19%)
XLP : 64.65 (+0.17%)
IHF : 208.41 (-0.33%)
IHI : 272.49 (-0.70%)
IYT : 195.91 (-1.14%)
THC : 34.20 (+5.07%)
RPT : 14.66 (+0.14%)
APEN : 2.70 (-3.57%)
BYND : 117.45 (-2.60%)
Apollo Endosurgery, Inc. to Present at the 12th Annual LD Micro Conference

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that company management will present...

APEN : 2.70 (-3.57%)
Apollo Endosurgery, Inc. to Present at the 31st Annual Piper Jaffray Healthcare Conference

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that company management will present...

APEN : 2.70 (-3.57%)
Apollo Endosurgery, Inc. to Host Investor Meetings at Craig-Hallum Alpha Select Conference

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that Todd Newton, CEO, and Stefanie Cavanaugh,...

APEN : 2.70 (-3.57%)
Apollo Endosurgery, Inc. Reports Third Quarter 2019 Results

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the third quarter...

APEN : 2.70 (-3.57%)
Apollo Endosurgery, Inc. to Report Third Quarter Results on October 30, 2019

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release...

APEN : 2.70 (-3.57%)
Apollo Endosurgery Receives 510(k) Clearance for Polypropylene Suture-Anchor Assembly

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that it has received 510(k) clearance...

APEN : 2.70 (-3.57%)
Apollo Endosurgery, Inc. Announces Closing of $20 Million Private Placement of Convertible Debentures

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it has closed its previously announced...

APEN : 2.70 (-3.57%)
Apollo Endosurgery, Inc. Announces $20 Million Private Placement of Convertible Debentures

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it has entered into definitive agreements...

APEN : 2.70 (-3.57%)
Apollo Endosurgery, Inc. Reports Second Quarter 2019 Results

Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter...

APEN : 2.70 (-3.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade APEN with:

Business Summary

Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for...

See More

Key Turning Points

2nd Resistance Point 2.85
1st Resistance Point 2.77
Last Price 2.70
1st Support Level 2.65
2nd Support Level 2.61

See More

52-Week High 4.08
Fibonacci 61.8% 3.48
Fibonacci 50% 3.29
Fibonacci 38.2% 3.10
Last Price 2.70
52-Week Low 2.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar